Crohn's disease: open trials in Puerto Rico

• NCT06937099

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  Trial Treatment · Phase 3 · Eli Lilly and Company

  CMRC Headlands, LLC, San Juan

  Registry updated 2026-11-04

• NCT06819891

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Galenus Group Of Puerto Rica Inc, Manati

  Registry updated 2026-10-26

• NCT07184931

  An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Sanofi

  Puerto Rico Health and Wellness Institute-Site Number: 8400104, Dorado · Wellness Clinical Research - Vega Baja-Site Number: 8400099, Vega Baja

  Registry updated 2026-10-21

• NCT05995353

  A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · AbbVie

  Puerto Rico Health Institute /ID# 255071, Dorado · Clinical Research Puerto Rico /ID# 266479, San Juan

  Registry updated 2026-10-20

• NCT06819878

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  University of Puerto Rico Medical Sciences Campus, San Juan · Klinical Investigations Group, LLC, San Juan

  Registry updated 2026-10-16

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error